Samalizumab (Anti-CD200)
Samalizumab (Anti-CD200) is a humanized monoclonal antibody that specifically targets CD200. It can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research. MW :144.84 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2632 |
| Sku # | A2632-1mg*25 |
| Pricing | 1mg*25, $2970.00 |